News Conference News TCT 2012 COURAGE, FAME: Revascularization More Effective Than OMT October 22, 2012
News Industry News Boston Scientific Announces FDA Approval and U.S. Launch of PROMUS® 2.25 mm Everolimus-Eluting Coronary Stent System May 25, 2011
News Industry News Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V® April 03, 2011
News Industry News Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent January 25, 2011